MorganSLevy Profile Banner
Morgan S. Levy, MD, MPH (she/her) Profile
Morgan S. Levy, MD, MPH (she/her)

@MorganSLevy

Followers
3K
Following
50K
Media
867
Statuses
8K

PGY2 @RadoncUK '29 | @S_W_R_O Communications Chair | #gyncsm, #bcsm, brachytherapy, survivorship, physician workforce equity | @HPVRoundtable | Views = mine

Joined June 2009
Don't wanna be here? Send us removal request.
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
7 months
What is the current state of gender inequity in institutional leadership roles at US academic medical centers? Out today in @JAMANetworkOpen , our scoping review analyzed data from 94 articles between 2019-2022. https://t.co/Lia04LaOWg 1/3
2
9
12
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
6 hours
When you get up for one minute and your cat decides to steal your seat. 🤣 #radonc #catmedtwitter
0
0
1
@NicholasZaorsky
Nicholas Zaorsky, MD MS
5 days
How to pack for a professional conference All this using only 1 carry-on + 1 personal item, no checked luggage 🙂 Work with @TrudyWuMD
18
43
297
@dsouzl
Leah D'Souza, MD, MSc
19 days
For those of us that missed #ASTRO2025, what are some good high yield summary resources/twitter threads of the meeting (aka Coles Notes for the CDNs 🇨🇦 or Cliff Notes for the Americans🇺🇸). Tagging the summary guru's that immediately come to mind @NiuSanford @jryckman3
3
6
11
@Dr_ElvinaA
Elvina Almuradova
21 days
PORTEC-3 : CRT vs Rt in high-risk endometrial cancer 10-year clinical outcomes and post-hoc analysis by molecular classification! • 10-year OS: 74.4% vs 67.3% (HR 0.73, p=0.032) • 10-year RFS: 72.8% vs 67.4% (HR 0.74, p=0.034) 💡 Greatest survival benefit seen in p53-abnormal
2
24
69
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
20 days
It is so important for patients to have equitable access to interventions that promote quality of life during cancer treatment, including scalp cooling, if they desire it! Hopeful that more states follow from here. #bcsm #gyncsm
@ABC
ABC News
21 days
Starting next year, New York will become the first state in the nation to require that private insurance companies cover scalp cooling for chemotherapy patients. Read more: https://t.co/0roKHGVIlL
0
0
5
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
20 days
Key trial from #ASTRO25 utilizing PAM50 as a biomarker to predict utility of apalutamide in intermediate risk prostate cancer recurrent post RALP. Androgen suppression has health and quality of life impacts, knowledge is power in shared decision making for these patients. #pcsm
@HemOncToday
HemOnc Today
21 days
🧪 A genetic test could help personalize treatment for recurrent #ProstateCancer. New phase 3 trial data presented at #ASTRO25 show @JNJInnovMed’s #Erleada  delivers biggest benefit for men with luminal B tumors. https://t.co/eSwjwbcq7O
1
0
3
@chibaAkiko
Akiko Chiba, MD, FACS
22 days
Excellent overview of screening after breast cancer ⁦@AnnaWeissMD⁩ 🔹Annual mammo after BCS (no utility of more frequent imaging) 🔹Supplemental MR for high risk 🔹No routine screening after mastectomy #ACSCC25@AmCollSurgeons
3
8
31
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
23 days
I am more excited than ever to come back and keep learning to provide the best care for my patients, work on research, and build a career as an academic radiation oncologist focusing on gynecologic cancers! Thank you to everybody who made it possible to attend. ☢️💕 2/2
1
0
2
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
23 days
Reflecting on this week at #ASTRO25! It was an incredible experience to attend my first Rad Onc conference and have the opportunity to learn, connect with others, and grow my skills in digital communications with @s_w_r_o_ and as a social media champion for ASTRO. 1/2
1
2
16
@BenjaminKingMD
Benjamin King, MD
26 days
@MorganSLevy @ASTRO_org @ACRORadOnc @NRGonc @SGO_org @gyncsm @TimeTitansTweet @AcceleratorsRO @QuadShotNews @AtTheBeam @AmericanBrachy @IJGConline Heard about this one at #ASTRO25. It is a great resource to stay informed about policy and to get involved in advocacy for the future viability of #radonc and for our patients! #ROCR #RUC #healthpolicy @daveadler10
3
2
7
@NicholasZaorsky
Nicholas Zaorsky, MD MS
26 days
The best time to update your academic CV is on the flight back from a conference #ASTRO25 #radonc Use our CV and cover letter writing guide via @ASTRO_org @ARRO_org @CWRUSOM @DrChrisCorso @yazshaz Slides: https://t.co/V73YV6DYBf Talk: https://t.co/Lxda7BD9GX
2
19
88
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
27 days
I have been loving podcasts as an education tool since starting PGY2! Always looking for new recommendations, curious what other podcasts people recommend? Mostly looking for content in #radonc, #gyncsm, #bcsm, general oncology, and health equity. @ASTRO_org #medicaleducation
5
6
23
@pipcosper
Pippa Cosper MD, PhD
27 days
Wonderful grant writing workshop at #ASTRO25 with very helpful slide deck. Great advice by the experts…. Now time to buckle down and write 😱
1
5
18
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
27 days
With that, your friendly neighborhood @ASTRO_org social media girl is officially off duty! ✅☢️💕 A recap in numbers: - Accounts tweeted from: 3 - Photos taken: 340 - Tweets: 105 - Twitter to IRL meetups: too many to count - Portable battery charges: 8 - Sessions: 15 #ASTRO25
3
0
33
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
28 days
In training, we do not currently get formal training on social media. But this is where so many of our patients seek health information, and sharing good information where patients see it has an impact. It is also a powerful way to connect with others!! #ASTRO25 2/2
0
0
1
@MorganSLevy
Morgan S. Levy, MD, MPH (she/her)
28 days
Dr. Lin on how to advocate for funding for cancer research. “We need to share our voices on every platform possible.” I am biased, but do personally believe in the power of physicians on social media! (And yes I do know of @DGlaucomflecken) @ASTRO_org #ASTRO25 1/2
1
3
9